Pages that link to "Q57225840"

The following pages link to Calcium supplementation with and without hormone replacement therapy to prevent postmenopausal bone loss (Q57225840):

Displaying 50 items.

• Hormone replacement therapy for preventing cardiovascular disease in post-menopausal women (Q24244146) (← links)
• Calcium supplementation on bone loss in postmenopausal women (Q24245007) (← links)
• Calcium supplementation on bone loss in postmenopausal women (Q24247398) (← links)
• Calcium intake and bone mineral density: systematic review and meta-analysis (Q26784337) (← links)
• Treatment of osteoporosis with calcium and vitamin D. Systematic review (Q30898904) (← links)
• Hormone replacement therapy: II. A pharmacoeconomic appraisal of its role in the prevention of postmenopausal osteoporosis and ischaemic heart disease (Q33560669) (← links)
• Racial bias in federal nutrition policy, Part I: The public health implications of variations in lactase persistence. (Q33863462) (← links)
• Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution (Q33909569) (← links)
• Antiosteoporotic effects of Polycan in combination with calcium lactate-gluconate in ovariectomized rats (Q33962186) (← links)
• Calcium and vitamin D in osteoporosis (Q34206961) (← links)
• Effect of Calcium and Vitamin D Supplementation on Bone Density in Men and Women 65 Years of Age or Older (Q34437473) (← links)
• The effect of low calcium diet on bone in ovariectomized mice (Q35047199) (← links)
• The risks and benefits of calcium supplementation (Q35260948) (← links)
• Multiple sources of dietary calcium-some aspects of its essentiality (Q35710621) (← links)
• Screening, supplements and the use of hormonal replacement therapy in postmenopausal women in a family medicine department prior to the publication of the Woman's Health Initiative report. (Q35861443) (← links)
• Managing elderly people's osteoporosis. Why? Who? How? (Q36577705) (← links)
• Safety and efficacy of polycalcium for improving biomarkers of bone metabolism: a 4-week open-label clinical study (Q36687085) (← links)
• The use of calcium and vitamin D in the management of osteoporosis (Q37052780) (← links)
• Urinary calcium excretion in postmenopausal African American women (Q37054202) (← links)
• Change in bone mineral density during adjuvant chemotherapy for early-stage breast cancer (Q37195016) (← links)
• The remodeling transient and the calcium economy (Q37421681) (← links)
• The effect of calcium supplementation on bone loss in 32 controlled trials in postmenopausal women (Q37490907) (← links)
• A critical review of racial/ethnic variables in osteoporosis and bone density research (Q37826095) (← links)
• Calcium supplementation in postmenopausal women to reduce the risk of osteoporotic fractures (Q37834875) (← links)
• Heated oyster shell-seaweed calcium (AAA Ca) on osteoporosis (Q38531015) (← links)
• The role of vitamin D and calcium supplementation in the prevention of osteoporotic fractures in the elderly (Q40430742) (← links)
• Mineral requirements of elderly people (Q40474743) (← links)
• Age-related osteoporosis. (Q40589541) (← links)
• Prevention and Treatment of Osteoporosis: Does the Future Belong to Hormone Replacement Therapy? (Q40867107) (← links)
• When should bone density measurements be repeated? (Q41017994) (← links)
• Role of calcium and vitamin D in the prevention and the treatment of postmenopausal osteoporosis: an overview (Q41144171) (← links)
• Calcium insufficiency and fracture risk (Q41225852) (← links)
• Osteoporosis: Prevention, diagnosis, and management (Q41526019) (← links)
• Calcium and osteoporosis (Q41570299) (← links)
• Calcium for Prevention of Osteoporotic Fractures in Postmenopausal Women (Q41587056) (← links)
• Management of complications of glucocorticoid therapy (Q41611539) (← links)
• First- and second-year effects in trials of calcium supplementation on the loss of bone density in postmenopausal women (Q41682643) (← links)
• Calcium potentiates the effect of estrogen and calcitonin on bone mass: review and analysis (Q41688135) (← links)
• The calcium controversy. (Q41736037) (← links)
• Analysis of the progesterone displacement of its human serum albumin binding site by β-estradiol using biochromatographic approaches: effect of two salt modifiers (Q44633670) (← links)
• Interactions of interleukin-6 promoter polymorphisms with dietary and lifestyle factors and their association with bone mass in men and women from the Framingham Osteoporosis Study (Q44789769) (← links)
• Accelerated bone mineral loss following a hip fracture: A prospective longitudinal study (Q50948114) (← links)
• Acute changes in serum calcium and parathyroid hormone circulating levels induced by the oral intake of five currently available calcium salts in healthy male volunteers (Q57224613) (← links)
• The women's health initiative calcium–vitamin D trial: overview and baseline characteristics of participants (Q58217068) (← links)
• Using Mendelian Randomization to Decipher Mechanisms of Bone Disease (Q58753623) (← links)
• The use of complementary and alternative medications by menopausal women in South East Queensland (Q58880292) (← links)
• Evidence that increased calcium intake does not prevent early postmenopausal bone loss (Q58972112) (← links)
• A high dietary calcium intake is needed for a positive effect on bone density in Swedish postmenopausal women (Q59806902) (← links)
• Diet, bone mass, and osteocalcin: A cross-sectional study (Q59807041) (← links)
• Estrogen and calcium supplement use among Japanese-American women: effects upon bone loss when used singly and in combination (Q70929892) (← links)